Перевести на Переведено сервисом «Яндекс.Перевод»

Kirov site to make French technology based vaccine against children’s infections

Nanolek, a Russian biotech company, has agreed with France’s Sanofi Pasteur, a global leader in vaccine development, on the setup of Russian-based production of a vaccine to prevent dangerous children’s diseases, Rusnano reported. The Russian nanotech giant established Nanolek as its portfolio company back in 2011.

According to the partners’ memo of understanding, Nanolek is planning to use its production site in the Kirov region some 950km north-east of Moscow in the Volga area to manufacture what’s to be called «Pentaxim," a five-component combined vaccine to protect against five infectious diseases simultaneously. These reportedly include diphtheria, pertussis, tetanus, polio and the B-type blood-borne (hemophilia) infection.

The MoU is paving the way for Sanofi Pasteur to transfer its vaccine technology to its Russian partner.

http://marchmontnews.com/Industry-Manufacturing/Volga/21330-Kirov-site-make-French-technology-based-vaccine-against-childrens-infections.html

Log in or sign up on  to add a comment to scientific problem you are interested in!
Comments (0)